Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer (Q42488113)

1 November 2017

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer (English)

1 reference

1 November 2017

1 reference

2

Hitoshi Tsuda

1 reference

1 November 2017

12

Takayuki Kinoshita

1 reference

1 November 2017

3

Chikako Shimizu

1 reference

1 November 2017

15

Yasuhiro Fujiwara

1 reference

1 November 2017

8

Kan Yonemori

1 reference

1 November 2017

10

Kenji Tamura

1 reference

1 November 2017

9

Masashi Ando

1 reference

1 November 2017

11

Noriyuki Katsumata

1 reference

1 November 2017

5

Tatsuhiro Shibata

1 reference

1 November 2017

7

Taizo Hirata

1 reference

1 November 2017

6

Harukaze Yamamoto

1 reference

1 November 2017

1

Makiko Ono

1 reference

1 November 2017

Sohei Yamamoto

4

1 reference

1 November 2017

Yuichi Takiguchi

series ordinal

13

1 reference

1 November 2017

Hideki Tanzawa

series ordinal

14

1 reference

1 November 2017

language of work or name

English

0 references

publication date

12 May 2011

1 reference

Breast Cancer Research and Treatment

1 November 2017

1 reference

1 November 2017

132

1 reference

1 November 2017

3

1 reference

1 November 2017

793-805

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1554-7

1 November 2017

0 references

cites work

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Basal-like breast cancer and the BRCA1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1554-7

10.1007/S10549-011-1554-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference